Heparinex LLC Receives $1.6 Million EDGE Award to Enable Chemistry, Manufacturing and Controls for its Proprietary Heparosan Drug Delivery Technology
11/28/2011 10:24:22 AM
OKLAHOMA CITY & AUSTIN, Texas--(BUSINESS WIRE)--Heparinex, L.L.C., a biopharmaceutical company with patented drug delivery technology platforms, announced the Company has received a $1.6 million fund endowment from the Economic Development Generating Excellence program (EDGE). Heparinex and the University of Oklahoma Health Sciences Center have discovered a drug delivery technology that utilizes sugar-polymers to more safely and effectively deliver drugs used in the treatment of a number of diseases.
comments powered by